Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) EBIT Margin (2020 - 2025)

Historic EBIT Margin for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to 8.34%.

  • KORU Medical Systems' EBIT Margin rose 124800.0% to 8.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.28%, marking a year-over-year increase of 117700.0%. This contributed to the annual value of 19.16% for FY2024, which is 168500.0% up from last year.
  • KORU Medical Systems' EBIT Margin amounted to 8.34% in Q3 2025, which was up 124800.0% from 3.07% recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' EBIT Margin registered a high of 3.07% during Q2 2025, and its lowest value of 55.2% during Q2 2022.
  • Its 5-year average for EBIT Margin is 27.61%, with a median of 24.98% in 2021.
  • Its EBIT Margin has fluctuated over the past 5 years, first tumbled by -499600bps in 2021, then soared by 323500bps in 2024.
  • KORU Medical Systems' EBIT Margin (Quarter) stood at 32.56% in 2021, then fell by -5bps to 34.19% in 2022, then rose by 11bps to 30.58% in 2023, then surged by 41bps to 17.98% in 2024, then soared by 54bps to 8.34% in 2025.
  • Its EBIT Margin stands at 8.34% for Q3 2025, versus 3.07% for Q2 2025 and 12.92% for Q1 2025.